genome-wide association study
-
What is a genome?
The human genome comprises approximately three billion base pairs of DNA, encompassing all chromosomes of the human organism. It includes coding regions that encode genes and noncoding regions.
Genome-wide association studies (GWAS) systematically scan the human genome for genetic variations, particularly single nucleotide polymorphisms (SNPs), to identify associations with diseases and other traits. GWAS results can predict disease risk, enhance understanding of genetic underpinnings, and elucidate the biological roles of genetic variations, with applications in personalized medicine and therapeutics.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is a gene and how does it affect traits?
A gene is a segment of DNA that serves as a functional unit of heredity. Genes are composed of a specific sequence of nucleotides and located on a chromosome. They control the transmission and expression of traits by specifying the structure of proteins.
Genes influence an organism's traits, also known as the phenotype. The phenotype includes observable characteristics such as behavior, color, shape, and size. Genes exert their influence by determining the structure and function of proteins.
A genome-wide association study (GWAS) is a method used to scan the genome for genetic variations associated with particular diseases and traits. GWAS often focuses on single nucleotide polymorphisms (SNPs) to assess disease risk and responses to therapeutic agents. These studies require large sample sizes to identify statistically meaningful associations between genetic variations and traits.
6 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What does 'association study' mean in science?
A genome-wide association study (GWAS) systematically scans the human genome to identify genetic variations linked to specific diseases. These studies often focus on single nucleotide polymorphisms (SNPs), investigating hundreds or thousands of them in large groups of people to find statistically significant associations.
GWAS results can predict disease risk, enhance understanding of the genetic basis of diseases and traits, and elucidate the biological roles of genetic variations. This information is valuable in personalized medicine and therapeutics, where genotype data can inform disease risk assessment and treatment decisions. However, a key challenge is the complexity of interpreting the large number of identified variants, many of which have limited relevance to disease.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is a genome-wide association study (GWAS)?
A genome-wide association study (GWAS) is a method that rapidly scans the human genome for genetic variations to find associations between variants and particular diseases. GWAS often focuses on single nucleotide polymorphisms (SNPs) and is designed to investigate hundreds or thousands of SNPs in large numbers of individuals at once.
GWAS results are used for predicting disease risk, understanding the genetic underpinnings of diseases and other traits, and understanding the biological role of genetic variations. These studies are of particular interest in personalized medicine and therapeutics, where genotype information can assess an individualâs disease risk and inform treatment decisions. To identify statistically meaningful associations, GWAS require large sample sizes and data on genotype.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How are GWAS used to find genes linked to diseases or traits?
Genome-wide association studies (GWAS) systematically scan the human genome to find genetic variations linked to particular diseases. These studies often focus on single nucleotide polymorphisms (SNPs) and investigate hundreds or thousands of them in large groups of people to find statistically meaningful associations.
GWAS can predict disease risk and help researchers understand the genetic basis of diseases and other traits, informing personalized medicine and therapeutics. For instance, GWAS have identified over 125 genetic variants associated with schizophrenia. They can also reveal SNPs associated with responses to antiviral drugs like sofosbuvir for hepatitis C, guiding treatment decisions.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are some benefits and challenges of doing genome-wide association studies?
Genome-wide association studies (GWAS) involve rapidly scanning the human genome for genetic variations to identify associations with particular diseases. GWAS results can predict disease risk, help understand the genetic underpinnings of diseases and other traits, and elucidate the biological roles of genetic variations. They are especially useful in personalized medicine and therapeutics, where genotype information can inform treatment decisions and assess individual disease risk.
However, GWAS also face limitations. A general conclusion from GWAS is that many individual variations contribute to complex traits. Identifying so many variants, most of limited relevance to disease, would introduce insurmountable complexity to the interpretation of findings from genome-wide association studies. Also, attributing disease causation or therapeutic response to a genetic variant requires careful analysis across multiple disciplines.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
genome-wide association study (GWAS), systematic approach to rapidly scanning the human genome for genetic variations, with the aim of identifying associations between variants and particular diseases. Genome-wide association studies often concentrate on variations known as single nucleotide polymorphisms (SNPs) and are designed in ways that allow researchers to investigate hundreds or thousands of SNPs in large numbers of individuals at once. Variations that are identified in the genome can be used to assess not only disease risk but also other factors, such as response to certain therapeutic agents.
Developments
Genome-wide association studies were first used in the early 2000s, coincident with the completion of the Human Genome Project and the International HapMap Project and with the development of computer databases capable of storing the full human genome sequence and known variations. Subsequent growth in the application of genome-wide association studiesâand corresponding increases in computational demandsâfueled the development of improved data management systems. Of particular significance was a shift to the use of higher-performance computing technologies, particularly cloud-distributed computing systems, which are capable of storing incredible amounts of data and which facilitate data sharing, retrieval, and processing.
Methods
In general, to identify statistically meaningful associations, genome-wide association studies require large sample sizes, often consisting of tens of thousands of individuals, with data on genotype (genetic constitution). Different study designs may be used, depending on the question of interest. Case-control studies, for example, search for associations by comparing data from patients with the disease and data from healthy controls. Quantitative studies, on the other hand, search for associations involving traits that vary continuously in natural populations (e.g., blood pressure and weight). Genome-wide association studies further are focused on populations or family groups; family-based studies enable researchers to apply linkage analysis, a powerful means for identifying associations between inherited genetic factors and disease.
" height="20" alt="HEW Logo">
Data for genome-wide association studies may be drawn from tailored study cohorts or from preexisting or publicly available resources, such as biobanks. Genotype data already available in such resources or obtained in cohort studies generally is derived from microarray analysisâan effective means for identifying common variantsâor from next-generation sequencing, such as whole-genome sequencing, which can capture common and rare variants. Data on individuals included in a genome-wide association study typically undergoes extensive testing for quality control to remove flaws, such as errors in genotyping, prior to testing for associations.
Applications and limitations
Genome-wide association studies have various applications. In general, results from such studies are used for predicting disease risk, for understanding the genetic underpinnings of diseases and other traits, and for understanding the biological role of genetic variations. Genome-wide association studies are of particular interest in fields such as personalized medicine and therapeutics, where information on genotype can be used to assess an individualâs disease risk and to inform treatment decisions.
A general conclusion from genome-wide association studies is that many individual variations contribute to complex traits. For example, more than 125 genetic variants are associated with schizophrenia, with the variants differing in type and contribution to disease risk. An example of the successful application of genome-wide association studies in the realm of therapeutics is the investigation of the hepatitis C virus (HCV), in which analysis of HCV from infected individuals revealed SNPs associated with response to the antiviral drug sofosbuvir. The discovery suggested that results of HCV genotyping could be used to guide treatment decisions for HCV-infected patients.
Although genome-wide association studies have successfully identified connections between SNPs and disease and have cast light on biological pathways, the majority of variations that have been identified offer little novel insight into disease. Moreover, these studies, by linking hundreds or even thousands of variants to common illnesses, could eventually identify and associate one or more variants in every active region of DNA in a given tissue with a disease. In the absence of a more complete understanding of biochemical pathways, the identification of so many variantsâmost being of limited relevance to diseaseâwould introduce insurmountable complexity to the interpretation of findings from genome-wide association studies.
The trusted destination for professionals, college students, and lifelong learners.
SUBSCRIBE
